Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025

Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on March 28, 2025

NASHVILLE, Tenn.--(BUSINESS WIRE)--March 27, 2025-- 

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the "Investors" section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Friday, March 28, 2025, to discuss the results and provide a business update.

Conference Call Information

Participants can access the live conference call via webcast on the "Investors" page of Harrow's website. To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call. A replay of the conference call and webcast will be archived on the Company's website for one year.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250327176398/en/

 
    CONTACT:    Jamie Webb 

Director of Communications and Investor Relations

jwebb@harrowinc.com

615-733-4737

(END) Dow Jones Newswires

March 27, 2025 10:48 ET (14:48 GMT)